Can You Donate Plasma on Eliquis (Apixaban)? Blood Thinner Guide (2026)

Why Eliquis Causes Permanent Deferral

Eliquis (apixaban) is a Factor Xa inhibitor — it directly blocks one of the key enzymes in the blood clotting cascade. Unlike NSAIDs, which have mild and reversible effects on platelet function, Eliquis fundamentally impairs your blood's ability to clot. This creates two major problems for plasma donation:

Problem 1: Bleeding Risk at the Venipuncture Site

During plasmapheresis, a large-bore needle (16-17 gauge) is inserted into your arm vein. After the procedure, the needle is removed and pressure is applied to stop bleeding. On Eliquis:

• Extended bleeding time: The venipuncture site may take much longer to achieve hemostasis (stop bleeding)
• Hematoma risk: Blood can pool under the skin, causing large painful bruises
• Nerve compression: In rare cases, excessive bleeding can compress nearby nerves
• Rebleeding: Even after apparent hemostasis, the site may reopen and bleed hours later

Problem 2: Anticoagulant in Donated Plasma

Apixaban circulates in your plasma at therapeutic levels. When your plasma is collected, it contains active anticoagulant medication. This is problematic because:

• Plasma products must be safe: Plasma is used to manufacture clotting factors and immunoglobulins. An anticoagulant in the raw plasma could theoretically affect manufacturing
• Unpredictable concentrations: The amount of apixaban in your plasma varies based on when you last took your dose, your kidney function, and other factors
• Regulatory concern: The FDA and plasma fractionation companies have standards for acceptable plasma that exclude donors on anticoagulants

The Underlying Condition Also Matters

Eliquis is prescribed for conditions that themselves may independently disqualify you:

• Atrial fibrillation (AFib): Irregular heart rhythm — may disqualify depending on severity
• Deep vein thrombosis (DVT): Blood clots — typically a deferral
• Pulmonary embolism (PE): Lung blood clots — typically a deferral
• Post-surgical prophylaxis: If short-term after hip/knee replacement, deferral ends when medication stops

Understanding the DOAC Class

DOACs (Direct Oral Anticoagulants) are a newer generation of blood thinners that have largely replaced warfarin for many conditions. Understanding this drug class helps explain why all DOACs cause plasma donation deferral.

How DOACs Work

Unlike warfarin, which works indirectly by blocking vitamin K-dependent clotting factor synthesis, DOACs directly inhibit specific clotting factors:

• Factor Xa inhibitors (Eliquis, Xarelto, Savaysa): Block Factor Xa, a central enzyme in the clotting cascade
• Direct thrombin inhibitors (Pradaxa): Block thrombin (Factor IIa), the enzyme that converts fibrinogen to fibrin

DOAC Comparison Table

All DOACs result in plasma donation deferral. There is no DOAC that is accepted for plasma donation while you are actively taking it.

Eliquis vs Warfarin: Different Drugs, Same Deferral

If you have read our warfarin and blood thinners guide, you know that warfarin also causes deferral. Here is how Eliquis and warfarin compare:

Key difference: If your doctor discontinues Eliquis, you may become eligible for plasma donation sooner than someone coming off warfarin, because apixaban clears your system faster. However, the reason you were on the medication still matters — see Rare Exceptions below.

Rare Exceptions: When You Might Still Donate

While the standard answer is "no," there are a few narrow situations where Eliquis users might eventually become eligible for plasma donation:

Exception 1: Short-Term Post-Surgical Use

If Eliquis was prescribed for a limited duration after hip or knee replacement surgery (typically 12-35 days), you may become eligible once:

• Your prescribed course is completed
• You have been off Eliquis for at least 3-7 days (varies by center)
• Your surgical recovery is complete (3-12 months post-surgery depending on the procedure)
• You have no ongoing blood clotting conditions

Exception 2: Medication Switch

If your doctor switches you from Eliquis to a medication that is compatible with donation (very rare — most alternatives are also anticoagulants), you would need to:

• Be completely off Eliquis for 3-7 days
• Be on the new medication and stable
• Have the new medication approved by the center physician

Exception 3: Eliquis Discontinued

If your doctor determines you no longer need anticoagulation (for example, after successful cardioversion for AFib), you may become eligible after:

• Being off Eliquis for at least 7 days
• Having normal coagulation parameters confirmed
• Clearance from the plasma center physician
• The underlying condition no longer requiring treatment

Important: Never stop taking Eliquis without your doctor's explicit direction. Stopping an anticoagulant without medical supervision can cause life-threatening blood clots, strokes, or pulmonary embolisms. No amount of plasma donation income is worth this risk.

Understanding Bleeding Risk During Plasmapheresis

To understand why blood thinners are taken so seriously, it helps to know what happens during plasma donation and where bleeding complications can occur:

The Plasmapheresis Process and Bleeding Points

1. Venipuncture: A 16-17 gauge needle creates a significant puncture in your arm vein. On Eliquis, this wound may not form a proper clot.
2. During collection: Your blood is drawn out, separated in a centrifuge, and red cells are returned. The machine adds citrate anticoagulant. With Eliquis already in your system, this creates a double-anticoagulation effect.
3. Needle removal: After 45-90 minutes, the needle is removed. Normally, a clot forms within 5-10 minutes. On Eliquis, this may take 20-30+ minutes.
4. Post-donation: You hold gauze over the site. On Eliquis, the site may rebleed after you leave the center, potentially soaking through bandages.

Potential Complications

• Prolonged bleeding: Unable to achieve hemostasis at the venipuncture site
• Large hematoma: Blood pooling under the skin causing pain and potential nerve compression
• Arterial puncture complication: If the needle accidentally hits an artery, bleeding on Eliquis becomes a medical emergency
• Internal bleeding: The added citrate anticoagulant combined with Eliquis could theoretically exacerbate any existing minor internal bleeding

Related Blood Thinners and Donation Eligibility

Note: Low-dose aspirin (81 mg) is an antiplatelet agent, not a true anticoagulant, and is generally allowed for plasma donation. Do not confuse aspirin with prescription blood thinners like Eliquis.

Frequently Asked Questions

Is Eliquis a permanent deferral for plasma donation?

Yes, while you are actively taking Eliquis. The deferral continues as long as you are on the medication. If your doctor discontinues Eliquis and you meet other criteria, you may become eligible after a washout period.

Can I stop taking Eliquis to donate plasma?

Absolutely not. Never stop Eliquis without your doctor's direction. Stopping anticoagulation therapy without medical supervision can cause strokes, blood clots, and pulmonary embolisms. Plasma donation income is never worth risking your life.

Is Eliquis different from warfarin for donation purposes?

Both cause deferral. The difference is that Eliquis clears faster (1-2 days) than warfarin (5-7 days) if discontinued. But both require clearance from the center physician before donation can resume.

Can I donate if I only take Eliquis temporarily after surgery?

Potentially, once your course is complete and you have been off the medication for 3-7 days. You also need to meet any deferral period for the surgery itself, which may be 3-12 months.

Why is low-dose aspirin allowed but Eliquis is not?

Aspirin is a mild antiplatelet agent that slightly reduces platelet stickiness. Eliquis is a potent anticoagulant that directly blocks the clotting cascade. The bleeding risk with Eliquis is far greater, and the anticoagulant is present in the donated plasma.